286 related articles for article (PubMed ID: 2493801)
1. Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
Dhillon J; Mitchison DA
Br J Exp Pathol; 1989 Feb; 70(1):103-10. PubMed ID: 2493801
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
Dickinson JM; Mitchison DA
Tubercle; 1976 Dec; 57(4):251-8. PubMed ID: 827836
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.
Khor M; Lowrie DB; Coates AR; Mitchison DA
Br J Exp Pathol; 1986 Aug; 67(4):587-96. PubMed ID: 3091058
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. The immunizing properties of an isoniazid-resistant mutant of the Vallée strain of M. tuberculosis as compared with BCG; observations in the mouse and guinea pig.
HOBBY GL; LENERT TF; AUERBACH O
Am Rev Tuberc; 1954 Sep; 70(3):527-30. PubMed ID: 13189070
[No Abstract] [Full Text] [Related]
6. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
7. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
[TBL] [Abstract][Full Text] [Related]
8. The contribution of hydrogen peroxide resistance to virulence of Mycobacterium tuberculosis during the first six days after intravenous infection of normal and BCG-vaccinated guinea-pigs.
Jackett PS; Aber VR; Mitchison DA; Lowrie DB
Br J Exp Pathol; 1981 Feb; 62(1):34-40. PubMed ID: 6784743
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.
Shang S; Shanley CA; Caraway ML; Orme EA; Henao-Tamayo M; Hascall-Dove L; Ackart D; Orme IM; Ordway DJ; Basaraba RJ
Vaccine; 2012 Feb; 30(9):1572-82. PubMed ID: 22244979
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis.
McMurray DN; Carlomagno MA; Mintzer CL; Tetzlaff CL
Infect Immun; 1985 Nov; 50(2):555-9. PubMed ID: 3932212
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
13. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
[TBL] [Abstract][Full Text] [Related]
14. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
[TBL] [Abstract][Full Text] [Related]
15. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
Fabbrocini V
Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548
[No Abstract] [Full Text] [Related]
16. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
Nitti V; Ninni A; Natali P
Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
[No Abstract] [Full Text] [Related]
17. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
[TBL] [Abstract][Full Text] [Related]
18. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
19. Activity of rifampicin in experimental tuberculosis of the guinea pig.
Nitti V; Catena E; Ninni A; Di Filippo A
Chemotherapy; 1967; 12(6):369-400. PubMed ID: 4968843
[No Abstract] [Full Text] [Related]
20. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
Dworski M
Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
